e-Kare
eKare Inc. develops AI-powered digital wound care solutions for healthcare providers and clinical research organizations. Its inSight platform uses computer vision for 3D wound measurement, augmented by healBot generative AI assistant and eKare Gauss AI ecosystem.
- Company typePrivate
- Founded2015
- HeadquartersFairfax, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What e-Kare does
eKare Inc. is a private medical technology company that builds AI-powered digital wound care solutions for healthcare providers and clinical research organizations. Its core product, inSight, is a CE-marked and FDA-registered 3D wound imaging device that uses computer vision to capture precise wound measurements without physical reference markers, enabling standardized documentation at the point of care. The platform is CE Mark certified, ISO 13485 compliant, HIPAA and GDPR aligned, and supports 21 CFR Part 11 workflows, making it usable across routine clinical care and regulated clinical trial environments. Additional products include healBot, a generative AI conversational assistant for wound care workflows, and eKare Gauss, an AI ecosystem that allows organizations to build custom models on eKare's imaging pipeline.
Underlying the product surface is a deep learning stack comprising Mask-R-CNN for pressure injury detection (reported 92.6% accuracy), hybrid DCN/DNN models for wound etiology classification (reported 94% accuracy), LSTM networks for healing trajectory prediction, and a proprietary training dataset of more than 100,000 wound images. The platform integrates with major clinical and research data systems including Epic, Cerner, and Medidata Rave, and is offered alongside telehealth, point-of-care assessment, and business intelligence modules.
The business model combines hardware sales (inSight imaging systems), SaaS subscriptions, professional services, and API/integration fees, sold primarily through direct enterprise field sales targeting hospitals, wound care centers, NHS Trusts, CROs, and medical device and pharmaceutical companies such as ConvaTec, KCI, and Novartis. The company is headquartered in Fairfax, Virginia, with a European subsidiary (eKare Europe BV) in the Netherlands and operational presence in the UK. The leadership team includes CEO Patrick Cheng and Dr. Paul Kim.
e-Kare firmographics
Firmographics- Name
- e-Kare
- Legal name
- eKare Inc.
- Website
- https://ekare.ai
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- eKare Inc. develops AI-powered digital wound care solutions for healthcare providers and clinical research organizations. Its inSight platform uses computer vision for 3D wound measurement, augmented by healBot generative AI assistant and eKare Gauss AI ecosystem.
- Ownership category
- akta.pro rank
e-Kare industry classification
Industry- Product category
- Digital Wound Care Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Wound Care & Ulcer Management (HLAKACAN)
Keywords
Where e-Kare is headquartered
LocationHeadquarters
- HQ city
- Fairfax
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
e-Kare business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- Software as a Service (SaaS) Platform: Subscription-based model for wound imaging and management platform access, including inSight software, telehealth services, and AI analytics tools.
- Hardware Sales: Sale of inSight hardware systems including tablet computer, Structure Sensor, mounting bracket, connection cable, and power adapters. Hardware ownership remains with eKare unless otherwise agreed.
- Professional Services: On-site training, implementation, and additional services beyond standard agreement scope, including custom integrations and support.
- API and Integration Services: RESTful API access and pre-built integrations with EHR/EDC platforms including Epic, Cerner, and Medidata Rave for enterprise customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise healthcare organizations |
| Subscription | Multi-year contract | Clinical research organizations |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
e-Kare product offering
Product offeringCore offering
e-Kare provides a digital wound care platform centered on its CE-marked and FDA-registered inSight 3D wound imaging and measurement device, which uses computer vision technology to capture wound dimensions without reference markers. The platform bundles AI-powered clinical decision support (healBot), telehealth and remote patient monitoring, point-of-care bedside documentation, and EHR-integrated analytics dashboards for hospitals, clinics, and clinical research organizations.
Product overview
eKare offers a unified digital wound care platform built around its core inSight product, a CE-marked and FDA-registered wound imaging and measurement device. The platform consists of multiple integrated modules: inSight (core imaging and documentation), healBot (generative AI assistant with Reference, Analytics, and Advisor components), eKare Gauss (AI ecosystem for custom model development), Telehealth Services (remote monitoring and video conferencing), Point of Care Assessment, Advanced Wound Imaging, Business Intelligence/Analytics, and Clinical Workflow Optimization. The products work together as a fully-integrated suite for wound assessment, wound documentation, eVisits, and remote patient monitoring.
Differentiator
Problem solved
Functional benefit
Brands
- inSight: CE-marked, FDA-registered wound measurement device for high quality imaging and assessment using computer vision technology
- healBot
- eKare Telehealth
- eKare Gauss
- eKloud
Products and services
- inSight CE-marked and FDA-registered wound measurement device using computer vision technology to capture high-quality 3D wound images and dimensions without reference markers, available on iPad with Structure Sensor and on iPhone with built-in optics for healthcare providers.
- healBot Generative AI conversational assistant for wound care comprising healBot Reference (clinical guidance), healBot Analytics (conversational analytics dashboard), and healBot Advisor (wound-level decision support), integrated within the inSight platform to deliver evidence-based guidance on clinical protocols, product qualification, and reimbursement pathways.
- eKare Gauss End-to-end AI ecosystem providing data labeling, automatic AI model selection, and cloud deployment, with access to eKare's data lake of over 100,000 images, measurements and 3D scans for healthcare AI teams building wound care applications.
- Telehealth Services HIPAA and GDPR compliant telehealth solution enabling virtual patient-provider engagements, real-time live video conferencing, store-and-forward data sharing, remote patient monitoring, and direct-to-patient or decentralized clinical trial workflows, with a patient app for wound image capture.
- Point of Care Assessment Mobile wound care documentation solution enabling clinicians to evaluate healing progression and document wounds at the patient's bedside, with automatic data capture, real-time imaging feedback, workflow alignment, and secure web portal access across multi-unit healthcare networks.
- Business Intelligence Dashboard Customizable and configurable real-time wound care analytics dashboard providing clinical decision support and practice management, with instant overview of time-critical metrics, key aspects of clinical studies, and operational performance for healthcare providers and research organizations.
Quantifiable outcome
- 92.6% accuracy in pressure injury detection
- +4 more outcomes
Companies that use e-Kare
Customer profileNamed customers15 records
Segments3 records
Ideal customer profiles3 records
e-Kare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability14 records
Feature8 records
e-Kare partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and major.
- NIH - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)coreinSight wound management platform selected by NIDDK to support data collection and clinical monitoring for NIH-led Diabetic Foot Consortium national initiative for landmark diabetic foot ulcer research.
- NHS Digital Health Accelerator (East Midlands AHSN)coreinSight digital 3D imaging and wound measurement system selected to join NHS Digital Health Accelerator designed to speed up technology adoption in NHS by providing support to develop and deploy solutions to pressing NHS challenges.
- Epic SystemscorePre-built integration available through Epic App Orchard for seamless EHR connectivity. Epic is a registered trademark of Epic Systems Corporation.
- CernercorePre-built integration with Cerner for clinical data management and wound documentation within Cerner EHR ecosystem.
- Medidata (Dassault Systèmes)coreIntegration with Medidata Rave EDC system for clinical trial wound assessment data capture and management.
- Oxford Health NHS Foundation TrustmajorPartnership to demonstrate advanced digital wound management system within Oxford Health NHS Foundation Trust healthcare facilities.
- South Warwickshire NHS Foundation TrustmajorImplementation partnership where SWFT uses inSight to maximize efficiency and save resources. SWFT recognized for digital excellence at HSJ Awards using eKare technology.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
e-Kare competitors and assessment
Company assessmentDirect peers
- Swift Medical: Swift Medical provides AI-powered digital wound care imaging and management software for hospitals and post-acute providers, making it the closest direct competitor to eKare's inSight platform in clinical wound imaging.
- Aranz Medical: Aranz Medical's Silhouette system provides 3D wound measurement, imaging, and documentation for clinical and research use, comparable to eKare's inSight 3D wound assessment platform.
- MolecuLight: MolecuLight develops handheld fluorescence-based digital wound imaging devices that capture and quantify bacterial presence in wounds, competing directly with eKare's computer-vision wound measurement approach.
- WoundVision: WoundVision offers digital wound imaging and assessment tools combining thermal imaging and AI, overlapping with eKare's computer vision wound measurement and clinical decision support offering.
- Tissue Analytics (a Net Health company): Tissue Analytics offers an AI-powered wound imaging and analytics platform integrated with EHRs for hospitals and wound clinics, directly competing with eKare's wound measurement and documentation capabilities.
Emerging players
- Healthy.io: Healthy.io applies smartphone-based computer vision and AI to clinical assessments including wound and urinalysis imaging, sharing eKare's smartphone-first, AI-driven clinical imaging approach.
- Bruin Biometrics: Bruin Biometrics' SEM Scanner detects early-stage pressure injuries via sub-epidermal moisture sensing, an adjacent AI-enabled wound assessment technology serving similar hospital customers as eKare.
Broad incumbents
- Net Health: Net Health is a specialty EHR and analytics provider for wound care, rehab, and occupational health that now owns Tissue Analytics, directly competing with eKare in hospital and clinic wound documentation software.
- Smith & Nephew: Smith & Nephew is a large global wound care medtech incumbent selling dressings, NPWT, and increasingly digital wound management tools, making it both a potential partner and the dominant competitive threat to eKare.
- 3M Health Care (Solventum): 3M's Health Care business (now Solventum) is a major wound care and health IT player with the scale to bundle digital wound imaging into its broader portfolio, representing a significant competitive incumbent to eKare.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
e-Kare social profiles
Digital presencee-Kare compliance and trust
Trust signalCompliance10 records
e-Kare financial estimates
Financial estimateRevenue estimate
Valuation estimate
e-Kare leadership team
Management profileNumber of profiles
Profiles2 records
e-Kare subsidiaries and ownership
Company hierarchySubsidiaries1 record
e-Kare funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
e-Kare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about e-Kare
What does e-Kare do?
e-Kare provides a digital wound care platform centered on its CE-marked and FDA-registered inSight 3D wound imaging and measurement device, which uses computer vision technology to capture wound dimensions without reference markers. The platform bundles AI-powered clinical decision support (healBot), telehealth and remote patient monitoring, point-of-care bedside documentation, and EHR-integrated analytics dashboards for hospitals, clinics, and clinical research organizations.
Is e-Kare a public or private company?
e-Kare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was e-Kare founded?
e-Kare was founded in 2015. It employs 11 to 50 people.
Where is e-Kare based?
e-Kare is headquartered in Fairfax, United States, in the North America region.
How does e-Kare make money?
Four revenue lines are on record. Software as a Service (SaaS) Platform is the primary driver. The others are hardware Sales, professional Services and API and Integration Services.
Who are e-Kare's main competitors?
Direct peers on record are Swift Medical, Aranz Medical, MolecuLight, WoundVision and Tissue Analytics (a Net Health company). Emerging players are Healthy.io and Bruin Biometrics. Broad incumbents are Net Health, Smith & Nephew and 3M Health Care (Solventum).
Does e-Kare have an API?
Yes. eKare offers APIs for EHR integration and wound documentation. The APIs are hosted and managed in a secure cloud environment, making them scalable, easier to manage, and cost-effective. The API supports SMART on FHIR standards for maximum security and safe data access. RESTful APIs enable easy integration and faster data access in a convenient format. API is described as the most efficient for EHR integration and wound documentation, with pre-built integrations with Epic, Cerner, and Medidata Rave. Developer documentation is at ekare.ai/3d-wound-measurement-app-api.
What industry is e-Kare in?
e-Kare's product category is Digital Wound Care Software. Its primary akta.pro industry code is HLAKACAN, Wound Care & Ulcer Management. Its NAICS code is 334510 and its SIC code is 3845.